193 related articles for article (PubMed ID: 16515850)
1. Development and characterization of interleukin-18-loaded biodegradable microspheres.
Lagarce F; Garcion E; Faisant N; Thomas O; Kanaujia P; Menei P; Benoit JP
Int J Pharm; 2006 May; 314(2):179-88. PubMed ID: 16515850
[TBL] [Abstract][Full Text] [Related]
2. In vitro investigation of lipid implants as a controlled release system for interleukin-18.
Koennings S; Garcion E; Faisant N; Menei P; Benoit JP; Goepferich A
Int J Pharm; 2006 May; 314(2):145-52. PubMed ID: 16513302
[TBL] [Abstract][Full Text] [Related]
3. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
4. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
7. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
Paillard-Giteau A; Tran VT; Thomas O; Garric X; Coudane J; Marchal S; Chourpa I; Benoît JP; Montero-Menei CN; Venier-Julienne MC
Eur J Pharm Biopharm; 2010 Jun; 75(2):128-36. PubMed ID: 20226857
[TBL] [Abstract][Full Text] [Related]
8. Development of new polymer-based particulate systems for anti-glioma vaccination.
Sapin A; Garcion E; Clavreul A; Lagarce F; Benoit JP; Menei P
Int J Pharm; 2006 Feb; 309(1-2):1-5. PubMed ID: 16386390
[TBL] [Abstract][Full Text] [Related]
9. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of GDNF release from biodegradable PLGA microspheres.
Aubert-Pouëssel A; Venier-Julienne MC; Clavreul A; Sergent M; Jollivet C; Montero-Menei CN; Garcion E; Bibby DC; Menei P; Benoit JP
J Control Release; 2004 Mar; 95(3):463-75. PubMed ID: 15023458
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
Lin R; Shi Ng L; Wang CH
Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
[TBL] [Abstract][Full Text] [Related]
12. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
13. A novel hemostatic delivery device for thrombin: biodegradable poly(D,L-lactide-co-glycolide) 50:50 microspheres.
Smeets R; Gerhards F; Stein JM; Paz RM; Vogt S; Pautke C; Weitz J; Kolk A
J Biomed Mater Res A; 2011 Jan; 96(1):177-85. PubMed ID: 21105166
[TBL] [Abstract][Full Text] [Related]
14. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
15. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
16. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
17. Radiosterilisation of indomethacin PLGA/PEG-derivative microspheres: protective effects of low temperature during gamma-irradiation.
Fernández-Carballido A; Puebla P; Herrero-Vanrell R; Pastoriza P
Int J Pharm; 2006 Apr; 313(1-2):129-35. PubMed ID: 16495023
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of the fibronectin central cell binding domain from polymeric microspheres.
Bouissou C; Potter U; Altroff H; Mardon H; Van Der Walle C
J Control Release; 2004 Mar; 95(3):557-66. PubMed ID: 15023466
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
